Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000897069-25-001209
Filing Date
2025-07-28
Accepted
2025-07-28 16:19:40
Documents
1
Period of Report
2025-07-24

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3908
  Complete submission text file 0000897069-25-001209.txt   5392
Mailing Address 601 21ST STREET, SUITE 300 VERO BEACH FL 32960
Business Address 601 21ST STREET, SUITE 300 VERO BEACH FL 32960 443-776-3133
Processa Pharmaceuticals, Inc. (Issuer) CIK: 0001533743 (see all company filings)

EIN.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1430 US HIGHWAY 206 SUITE 200 BEDMINSTER NJ 07921
Business Address
Baluch Khoso (Reporting) CIK: 0001686223 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39531 | Film No.: 251155880